Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06XFS
|
|||
| Former ID |
DNC013372
|
|||
| Drug Name |
2-methyl-7-(pyridin-3-yl)quinoline
|
|||
| Synonyms |
CHEMBL231763; 2-methyl-7-(pyridin-3-yl)quinoline
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H12N2
|
|||
| Canonical SMILES |
CC1=NC2=C(C=C1)C=CC(=C2)C3=CN=CC=C3
|
|||
| InChI |
1S/C15H12N2/c1-11-4-5-12-6-7-13(9-15(12)17-11)14-3-2-8-16-10-14/h2-10H,1H3
|
|||
| InChIKey |
MALXWWORFUKTKQ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4415-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.